Bio-Medical Applications Of North Carolina, Inc. in Swansboro, North Carolina - Dialysis Center

Bio-Medical Applications Of North Carolina, Inc. is a medicare approved dialysis facility center in Swansboro, North Carolina and it has 10 dialysis stations. It is located in Carteret county at 1165 Cedar Point Boulevard, Swansboro, NC, 28584. You can reach out to the office of Bio-Medical Applications Of North Carolina, Inc. at (252) 393-2039. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of North Carolina, Inc. has the following ownership type - Profit. It was first certified by medicare in May, 2015. The medicare id for this facility is 342702 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applications Of North Carolina, Inc.
Location1165 Cedar Point Boulevard, Swansboro, North Carolina
No. of Dialysis Stations 10
Medicare ID342702
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


1165 Cedar Point Boulevard, Swansboro, North Carolina, 28584
(252) 393-2039
Not Available

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of North Carolina, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1205237096
Organization NameFresenius Medical Care Sea Spray
Doing Business AsBio-medical Applications Of North Carolina, Inc.
Address1165 Cedar Point Boulevard Cedar Point, North Carolina, 28584
Phone Number(252) 393-2039

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data24
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL13

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center33
    Adult patient months included in Kt/V greater than or equal to 1.2254
    Percentage of adult patients getting regular hemodialysis at the center93
    Percentage of pediatric patients getting regular hemodialysis at the center
  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center23
    Adult patient months included in Kt/V greater than or equal to 1.7144
    Percentage of adult patients getting regular peritoneal dialysis at the center90
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of North Carolina, Inc. with elevated calcium levels.

Patients with hypercalcemia61
Hypercalcemia patient months467
Patients with Serumphosphor65
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL30
Patients with Serumphosphor from 5.6 to 7 mg/dL22
Patients with Serumphosphor greater than 7 mg/dL11

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 67
Patient months included in arterial venous fistula and catheter summaries 294
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment84
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer7

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit